Explore how EGFR and KRAS G12C biomarkers reshape lung cancer care, from first-line choices to resistance, testing, and prognosis.
Misty D. Shields, MD, PhD
Advertisement
Articles by Misty D. Shields, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
COVID-19 or Flu? Symptoms Alone Can't Tell: Tammy Lundstrom, MD, JD
2
Contributor: Congress Can Bring Mental Health Care to the 21st Century
3
Lung Cancer Progress Drives Down US Cancer Death Rates
4
Panel Confronts the Practical Barriers to Bringing Bispecifics Into Community Myeloma Care
5